Sylvie Ménard - Concepedia

Author

Sylvie Ménard

Fondazione IRCCS Istituto Nazionale dei Tumori

Also Known As

Bradbury, F. Marzullo, M.L. Carcangiu, S Menard, S Ménard, S Mènard, S Ménard, S. Menard, S. Mènard, S. Ménard

464

Publications

21.5K

Citations

H-Index

106

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori University of Milan University of Liège European Institute of Oncology Tumori Foundation

About

Sylvie Ménard is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	92	6.1K
2	Natural Sciences	6	6	370
3	Health Sciences	5	5	397
4	Allergy	4	4	91
5	Engineering	3	3	451

Sylvie Ménard

183

Publications

18.5K

Citations

H-Index

Page 1

	Year	Citations
MicroRNA Gene Expression Deregulation in Human Breast Cancer Marilena V. Iorio, Manuela Ferracin, Chang‐Gong Liu, Cancer Research	2005	4K
MicroRNA Signatures in Human Ovarian Cancer Marilena V. Iorio, Rosa Visone, Gianpiero Di Leva, Cancer Research	2007	1.4K
Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2 Roberto Gennari, Sylvie Ménard, Francesco Fagnoni, Clinical Cancer Research	2004	507
Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy Valentina Ciravolo, Veronica Huber, Gaia C. Ghedini, Journal of Cellular Physiology Breast OncologyEndosome-derived NanovesiclesNovel TherapyExosomesMedicine	2011	498
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome Anna Bergamaschi, Elda Tagliabue, Thérese Sørlie, The Journal of Pathology Breast OncologyEngineeringPathologyGene Expression ProfilingTumor Biology	2007	383
microRNA-205 Regulates HER3 in Human Breast Cancer Marilena V. Iorio, Patrizia Casalini, Claudia Piovan, Cancer Research	2009	363
High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer. Mary L. Disis, Serenella M. Pupa, Julie R. Gralow, Journal of Clinical Oncology	1997	343
Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificity Silvia Miotti, Silvana Canevari, Sylvie Ménard, International Journal of Cancer	1987	317
FOXP3 Expression and Overall Survival in Breast Cancer Andrea Merlo, Patrizia Casalini, Maria Luisa Carcangiu, Journal of Clinical Oncology	2009	295
A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma. Sabina Carla Righetti, Gabriella Della Torre, S. Pilotti, PubMed MedicineP53 Gene MutationsPathologyGynecologyCancer Cell Biology	1996	281

Page 1